Search

Search Constraints

You searched for: Author/Creator Pasic, Ivan

Search Results

1. Allogeneic hematopoietic stem cell transplantation in patients with therapy‐related hematologic malignancies developing after multiple myeloma. (7th February 2022)

2. Anti‐thymocyte Globulin and Post‐Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen‐A and ‐B mismatched donors. (27th December 2021)

3. Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant. (13th October 2020)

6. Influence of FLT3‐ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML. (13th February 2019)

7. Lower dose of ATG combined with post-transplant cyclophosphamide for HLA matched RIC alloHCT is associated with effective control of GVHD and less viral infections. Issue 14 (6th December 2021)

8. Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR. (14th June 2021)

9. Prolactin, a potential biomarker for chronic GVHD activity. (26th October 2020)

10. Prolactin, a potential biomarker for chronic GVHD activity. (26th October 2020)